Related Experiment Videos
Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors
Insights
Calcium entry blockers (CEB) reduce vascular resistance by relaxing smooth muscle, primarily through inhibiting calcium influx. CEB selectively interfere with alpha 2-adrenoceptor stimulation, contributing to their vasodilator effects.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Vascular Biology
Background:
- Calcium entry blockers (CEB) are widely used for cardiovascular diseases.
- Their primary therapeutic characteristic is vasodilator potency, except for verapamil's antiarrhythmic activity.
Purpose of the Study:
- To review the pharmacology of CEB.
- To analyze their vasodilator potency and mechanisms of action.
- To investigate the selective interference of CEB with alpha-adrenoceptor stimulation.
Main Methods:
- Review of existing pharmacological literature on CEB.
- Analysis of studies investigating CEB effects on vascular smooth muscle.
- Examination of CEB interactions with alpha 1- and alpha 2-adrenoceptor stimulation.
Main Results:
- CEB relax vascular smooth muscle, reducing peripheral vascular resistance by inhibiting transmembrane calcium influx.
- CEB noncompetitively reduce vasoconstriction induced by alpha 2-adrenoceptor stimulation.
- CEB have minimal effect on vasoconstriction mediated by alpha 1-adrenoceptor stimulation.
Conclusions:
- CEB's vasodilator effect is linked to inhibiting calcium influx and selectively interfering with alpha 2-adrenoceptor-mediated vasoconstriction.
- This selective action on alpha 2-adrenoceptors may contribute to CEB's therapeutic benefits in cardiovascular disease.
Abstract:
The pharmacology of calcium entry blockers (CEB), as used in various types of cardiovascular disease, is reviewed. Their vasodilator potency is analyzed, which is the most common therapeutic characteristic of all CEB, apart from the antiarrhythmic activity of verapamil. All CEB relax vascular smooth muscle, particularly in arteriolar beds, thus reducing peripheral vascular resistance. Arteriolar relaxation appears to be associated with inhibition of transmembrane calcium influx. Recent studies have demonstrated that vasoconstriction induced by stimulation of vascular postsynaptic alpha 2-adrenoceptors, using selective agonists, is reduced by CEB through a noncompetitive mechanism. However, vasoconstriction evoked by selective excitation of vascular alpha 1-adrenoceptors remains virtually uninfluenced by CEB. The selective interference of CEB with alpha 2-adrenoceptor stimulation suggests that calcium movement is associated with alpha 2-adrenoceptor stimulation. This mechanism may further contribute to the vasodilator effect of CEB by inhibiting that part of vascular tone evoked by the stimulation of alpha 2-adrenoceptors by endogenous catecholamines.